This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. cloudant venture capital merger acquisition exit cloud software nosql database' Financial terms of the buy were not disclosed. in funding.
San Diego-based venture investor Avalon Ventures is the lead investor in a round for a developer of cloud-based, business collaboration software today. Avalon''s Rich Levandov was involved in the funding effort. teambox avalon ventures cloud software collaboration saas venture capital' READ MORE>>.
San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.
La Jolla-based venture capital investor Avalon Ventures is the lead in a round for cloud data storage firm TwinStrata , TwinStrata said today. TwinStrata, which is based in Masachusetts, said that Avalon lead its Series B funding round, which was worth $8M. Avalon's investment in TwinStrata was headed by Rich Levandov.
San Diego-based venture investment fund Avalon Ventures has made a seed investment in a developer of a social shopping service, LoopIt , according to the companies. Avalon's Rich Levandov was involved in the investment. Size of the funding was not announced. LoopIt is based in Cambridge, Mass.,
San Diego-based venture investor Avalon Ventures has backed a developer of video advertising products, Selectable Media , to the tune of $2M. Selectable Media, which is based in New York, lets users opt into branded video advertising in exchange for free access to content on web and mobile apps. READ MORE>>.
in venture capital investments in Q2 2013 across Southern California, spread across 80 deals. The report comes every quarter from PricewaterhouseCoopers LLP (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters. in investments across 90 deals. in investments across 90 deals. READ MORE>>.
La Jolla-based Avalon Ventures is the lead investor in the Series A round for Averon , a developer of mobile identity verification software this week. Avalon's Rich Levandov and Brady Borhmann both join Averon's board with the funding round. Averon, which is based in San Francisco, said it has raised $8.3M in a Series A funding.
San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration. READ MORE>>.
San Diego-based venture investor Avalon Ventures is the lead investor in a new, $10M funding round for AeroFS , a developer of private cloud collaboration software. Avalon's Rich Levandov represents Avalon Ventures on the AeroFS board. AeroFS said the Series B funding also included NHN Investment. READ MORE>>.
San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.
The latest venture capital totals from the PricewaterhouseCoopers/National Venture Capital Association''s MoneyTree Report was released this evening, tallying up $761.12M in investments in Q2 of 2014 in Southern California, up from Q2 of 2013, when $616.83M was invested in the region. Image courtesy Bigstock. READ MORE>>.
San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing. disease celiac lifescience biotech capital venture glaxosmithkline pharmaceuticals sitary ventures avalong' READ MORE>>.
San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. The company is led by Tim McIntire.
San Diego-based Otonomy , a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M The round was led by Novo Ventures and RiverVest Venture Partners, and also includes Domain Associates, TPG Biotech, and Avalon Ventures. in a Series B financing.
San Diego-based Otonomy , a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M Source of the new funding was not disclosed, however, one of its founders, Jay Lichter, is at San Diego venture firm Avalon Ventures, which has previously backed the company.
The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. Avelas Biosciences is developing a flourecent peptide which helps surgeons highlight cancer cells during surgery, specifically for breast cancer. READ MORE>>.
San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday.
San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding. READ MORE>>.
San Diego-based Amira Pharmaceuticals , a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb , the firms said late Thursday. Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures.
Chumby develops a Wi-Fi enabled, Internet device which acts both as a clock as well as a connection into internet services like Weather, news, and more. Tags: chumby venture capital linux internet electronic device consumer. According to the filing, the firm is in the midst of raising up to $9.786M in the round. READ MORE>>.
San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.
Chumby has previously raised funding from Avalon Ventures, JK&B Capital, Masthead Venture Partners, and O'Reilly AlphaTech Ventures. Chumby's Internet device allows users to run information widgets, and includes tools for developers which makes it easy to create those software widgets to connect to Internet services.
The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients. The firm's technology is based on technology developed by Nobel Prize winner Roger Tsien, Ph.D. The firm's CEO is currently Jay Lichter, who is also a Managing Director at Avalon Ventures.
San Diego-based Chumby , the developer of a Linux-based, programmable device which connects to Internet information, has linked with QNX Software Sytsems Co. , Chumby is headed by Derrick Oien, and backed by Avalon Ventures, JK&B Capital, Masthead Venture Partners, and O'Reilly AlphaTech Ventures. READ MORE>>.
San Diego-based aFraxis , a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announced, however, the company is venture backed by Avalon Ventures.
San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. According to AnaptysBio, it will receive an upfront license fee of $17M from TESARO, plus receive funding of costs incurred in related development programs, as part of an antibody program.
San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The company said the new funding will go towards its product pipeline and a potential filing for regulatory approval of its lead compound.
San Diego-based Otonomy , which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures. READ MORE>>.
San Diego-based Awarepoint , which develops real-time, location systems used for tracking patents and assets in a healthcare environment, said today that it has raised $14M in an additional financing round. HHIF contributed $7.5M
According to the company, the funding was led by OrbiMed Advisors, and also included Aperture Venture Partners, Osage University Partners, as well as Avalon Ventures, Domain Associates, Novo Ventures, RiverVest Venture Partners and TPG Biotech. Khuong of OrbiMed wil join the company''s board with the funding. READ MORE>>.
San Diego-based Otonomy , a biopharmaceuticals company developing treatments for disorders of the inner and middle ear, said Thursday that it has added Vickie Capps to its board of directors. Capps also sits on the board of RF Surgical Systems and Consonance Capital Partners, and had been on the board of SenoRx. READ MORE>>.
San Diego-based StackIQ , a developer of "bare metal" provisioning software, has been acquired by Teradata , Teradata said on Thursday. StackIQ was venture backed by Anthem Venture Partners, Grayhawk Capital, Avalon Ventures, and crowdfunding site OurCrowd. Financial terms of the acquisition were not announced.
San Diego-based Awarepoint , which develops systems for tracking equipment and patients in hospitals, reported today that it has hired four new executives onto its management team. Wallace was most recently at McKesson Corporation, as was Cosgrove; Arthur joins from Microsoft, and Gallecos from Cisco. READ MORE>>.
Janux Therapeutics is developing T cell engager immunotherapies. The company's biggest shareholders before the IPO were Avalon Ventures, RA Capital Healthcare, Orbimed, Bregua Corporation, and Correlation Ventures. The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.
San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.
San Diego-based AristaMD , a developer of telehealth software, which allows primary care providers to conduct and document electronic medical consultations, has raised $18M in a Series B funding round.
The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. The startup, based in the COI Pharmaceuticals cluster of companies in San Diego, is based on research developed by Bin Liu, Ph.D., READ MORE>>.
San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.
San Diego-based Otonomy , a firm developing products to treat disorders of the inner and middle ear, looks to have pulled in $14.2M in a round led by Novo Ventures and RiverVest Venture Partners, and which also included Domain Associates, TPG Biotech, and Avalon Ventures. According to the filing, the firm has now raised $24.2M
San Diego-based Ambit Biosciences , a developer of small molecule profiling tools being used for biopharmaceuticals development, has raised $6.5M Tags: ambit biosciences venture capital debt funding biopharmaceuticals lifescience. in an ongoing, debt round, according to a filing from the firm today.
San Diego-based E-Band Communications , a developer of millimeter-wave wireless transmission systems, said Wednesday that the firm has raised a Series C financing round. According to E-Band, the round was led by Hercules Technology Growth Capital, and also included Avalon Ventures.
San Diego-based biotechnology developer Synthorx announced today that it has named Patrick J. Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. Doyle as its Chief Business Officer. READ MORE>>.
San Diego-based Proximal Data , which develops serve-side caching software for accelerating I/O access to virtualized machines, said this morning that it has raised $2M in a Series B round of funding. The funding came from Divergent Ventures, along with existing investors Avalon Ventures.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content